Nutriband Inc (OTC: NTRB), a Nevada Corporation, has acquired 4P Therapeutics Inc, a transdermal drug delivery company, it was reported on Tuesday.
The deal is valued at a total of USD1,900,000 payable in both company stock and cash. 4P Therapeutics will receive 250,000 shares of common stock and a cash amount of USD400,000 and will now become the Pharmaceutical and Development unit of Nutriband Inc, with a specific focus on Transdermal and Topical Technologies, prescription drugs and clinical development.
Steven Damon, CEO of 4P Therapeutics, has been appointed to the Nutriband board of directors.
Nuevocor names new chief medical officer
ELIAS Animal Health names new chief revenue officer
enGene Holdings names new senior vice president, Urologic Oncology and Clinical Development
HealthTrackRx names new chief medical officer
PureTech announces launch of Seaport Therapeutics with USD100m Series A financing
REVIAN names new vice president of Healthcare Sales
Orsini Specialty Pharmacy names new CFO and EVP of Trade Relations and Account Management
Ligand Pharmaceuticals launches Pelthos Therapeutics to drive ZELSUVMI commercialisation
Soligenix announces agreement on design for second Phase 3 trial for HyBryte with EMA
Ratio Therapeutics names new chief business officer and director
Trevi Therapeutics names new vice president of Clinical Development
NeoImmuneTech names new president and chief executive officer